China Shineway Pharmaceutical Group Limited

CSWYF · OTC
Analyze with AI
12/31/2024
6/30/2024
12/31/2023
6/30/2023
Assets
Cash & Equivalents$6,140,153$857,937$738,300
Short-Term Investments$350,020$0$0
Receivables$1,201,877$178,711$166,677
Inventory$813,190$114,249$110,004
Other Curr. Assets$93,283$13,901$9,094
Total Curr. Assets$8,598,523$1,164,798$1,024,075
Property Plant & Equip (Net)$1,219,402$166,938$170,588
Goodwill$165,956$22,836$22,840
Intangibles$23,323$3,818$28,132
Long-Term Investments$0-$12,389$0
Tax Assets$34,326$12,395$2,400
Other NC Assets$0-$10,683-$22,840
Total NC Assets$1,443,007$195,297$201,119
Other Assets$0$0$0
Total Assets$10,041,530$1,360,095$1,225,194
Liabilities
Payables$402,964$63,391$387,013
Short-Term Debt$338,271$54,087$303,607
Tax Payable$84,270$9,396$13,386
Deferred Revenue$0$16,679$10,992
Other Curr. Liab.$1,624,491$191,491-$418,208
Total Curr. Liab.$2,449,996$335,043$285,799
LT Debt$8,256$1,703$660
Deferred Rev, NC$81,853$0$22,380
Deferred Tax Liab, NC$34,521$0$3,120
Other NC Liab.$0$13,851-$160,353
Total NC Liab.$124,630$15,554$25,591
Other Liabilities$0$0$0
Cap. Leases$16,527$10,382$4,267
Total Liabilities$2,574,626$350,597$311,389
Equity
Pref Stock$0$0$0
Common Stock$87,662$12,062$12,064
Retained Earnings$6,726,436$923,526$835,826
AOCI$0-$68,097$87,454
Other Equity$652,806$142,007-$21,540
Total Equity$7,466,904$1,009,498$913,805
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$10,041,530$1,360,095$1,225,194
Net Debt-$5,793,626-$802,147$0-$434,033